Background Neuroblastoma is the most common solid tumour in infancy but its aetiology is largely unknown. Prenatal factors might play a key role in its pathogenesis. Previous studies investigated whether birth weight is associated with risk of neuroblastoma, with conflictive results. We conducted a meta-analysis to quantitatively summarize the published evidence.
Introduction
Neuroblastoma, a solid tumour arising from primitive sympathetic neural precursor cells, has an incidence rate of approximately 40 per 1 000 000 infants in the first year of life, thereby being the most common malignancy in infancy. 1 It has been termed a 'clinical enigma' of cancer research because of its hard-to-predict biological behaviour, spanning from spontaneous regression to very rapid metastatic spread, thereby making diagnosis, therapy and prognosis difficult. 2 Efforts to establish measures of secondary prevention, like newborn screening for vanillylilmandelic acid in urine, gave controversial results.
Importantly, no clear-cut risk factor for neuroblastoma has been identified so far. Because of its appearance very early in life it has been suggested that risk factors that act prenatally could play a role in the pathogenesis of neuroblastoma. However, conflictive data have been accumulated over the past few years on such factors like exposure to maternal smoking, 5 maternal medication 6 or vitamins during pregnancy, 7 possibly arising from the relatively small number of studies performed so far, or from the difficulties to correctly obtain the respective exposures during pregnancies. An alternative attempt is to focus on indicators of exposures that can be easily obtained in large samples with little bias and are established markers of the intrauterine environment. Birth weight can be considered to be such a marker: it is routinely obtained at birth by trained personnel with little systematic error and is generally recorded in medical records or registries. 8 Studies suggest that environmental factors such as maternal nutrition and maternal diseases are important for birth weight. 9, 10 In the past, a number of investigators have studied birth weight in infants and children with neuroblastoma. [11] [12] [13] A recent narrative review came to the conclusion that there might be an association of neuroblastoma risk with low birth weight. 14 Here, we aimed to quantify the association and performed a meta-analysis on the relation between birth weight and risk of neuroblastoma.
Methods
We performed a comprehensive literature search according to the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group guidelines for meta-analyses of observational studies, 15 including the databases MEDLINE (1966 ( to December 2008 and EMBASE (1989 to December 2008 to identify studies that investigated the association between birth weight and risk of neuroblastoma, using the terms 'birth weight' and 'neuroblastoma'. The entire search was performed in the full-text option, without language restrictions. Furthermore, we manually searched all references cited in original studies and reviews identified.
To be eligible, a study had to fulfil the following criteria, defined a priori: (i) it had to be an original report on birth weight and risk of neuroblastoma, and (ii) odds ratios (ORs) and 95% confidence intervals (CIs, or data with which to calculate them) for risk of neuroblastoma in at least two strata of birth weight had to be presented. Alternatively, an OR and 95% CI for the change in neuroblastoma risk per unit change in birth weight had to be reported. If only data for risk ratio were reported (cohort studies), they were used for pooling, since under the rare-disease assumption OR and risk ratio are nearly equal. 16 The course of the systematic literature review is illustrated in Figure 1 .
From all studies included, data were abstracted in duplicate, using a standardized form. The following study characteristics were extracted: publication year, country, region, study design, year of birth, age at diagnosis, study size, matching ratio (if case-control study), matching variables (if case-control study), source of controls (if case-control study), source of case diagnosis, source of data for birth weight, effect measures and confounders. An independent reviewer confirmed all data entries.
Three different meta-analytic approaches were used: (i) a birth weight cutoff of 4000 g (high birth weight) 17 was used to compare risks of neuroblastoma above and below this value (dichotomous comparison); (ii) the dichotomous approach was repeated for a birth weight cutoff of 2500 g (low birth weight) 17 ; and (iii) the pool-first method 18 was used to combine regression coefficients obtained from the studies for trend analysis.
For dichotomous comparisons, we extracted data on numbers of subjects with and without neuroblastoma above or below the cutoff value and calculated corresponding crude ORs and 95% CIs. We constructed both fixed-effects and random-effects models to estimate the pooled ORs for risk of neuroblastoma above vs below the respective cutoff value across all studies.
To studies that provided data for more than two categories of birth weight, we applied the 'pool-first method' to quantify the dose-response relationship between birth weight and risk of neuroblastoma. This method, as introduced by Greenland and Longnecker, 18 allows the meta-analytic pooling of regression data, but accounts for the fact that estimates used to calculate single regression coefficients are correlated to each other within one study. This problem is solved by first pooling the data within each study ('pool first') to obtain respective regression coefficients for each study, followed by pooling these regression coefficients. The resulting pooled regression coefficient can be interpreted like a regression coefficient from a single study. Visual inspection of the plots of 11 out of the 12 individual studies revealed a U-shaped relation between birth weight and risk of neuroblastoma. For each of these studies a study-specific linear and a quadratic regression coefficient and corresponding 95% CIs were calculated using a log-quadratic model. Following the pool-first approach, 18 the resulting linear and quadratic regression coefficients and their 95% CIs were pooled using a random-effects model. After having performed the sensitivity analyses (see below), we repeated the pool-first analysis, now applying a linear model restricted to the birth-weight spectrum 42500 g and to studies that used registries to obtain birth-weight data.
Heterogeneity of study results was assessed by calculating the I 2 , as proposed by Higgins et al., 19 I 2 , ranging from 0 to 100%, is a direct measure of inconsistency of study results in a meta-analysis. Robustness of the pooled estimate was checked by influence analysis, using a random-effects model: each of the study estimates was individually omitted from the data set, followed in each case by recalculation of the pooled estimate of the remaining studies.
Four different subgroup analyses were performed to identify potential sources of heterogeneity between study results. First, we calculated separate estimates for all studies from North America (USA and Canada) and for studies from Europe. Secondly, we stratified all studies according to method of obtaining birth weight (registry/certificate vs interview). Thirdly, subgroup estimates were calculated according to method of obtaining case diagnosis (registry vs others). Fourthly, we stratified all studies according to source of controls (registry/certificate vs others). For all analyses, a random-effects model was used.
Publication bias was assessed by inspection of the funnel plot, and formal testing for funnel plot asymmetry using Begg's test and Egger's test.
All calculations were performed using STATA 8 (Stata corporation, College Station, TX, USA).
Results
During the systematic review, we identified 13 studies that provided data on birth weight and subsequent risk of neuroblastoma. One study 20 had to be excluded since only an adjusted OR was reported for neuroblastoma after high birth weight (OR 1.40; 95% CI 0.90-2.20; adjusted for maternal age, birth order, weeks of gestation and sex) and an unadjusted OR could not be calculated from the data. Another study 12 had to be excluded since case overlap to a previous study 21 was substantial. Thereby, a total of 11 studies could be used for meta-analysis ( Figure  1) . 11, 13, [21] [22] [23] [24] [25] [26] [27] [28] [29] Study characteristics of included reports are shown in Table 1 . Studies involved a total of 2 159 927 individuals, of whom 3004 suffered from neuroblastoma. One study was a cohort study. The remaining 11 studies had a case-control design with matching ratios ranging from 1:1 to 1:10. The first study was published in 1985, whereas the most recent appeared in 2008. Studies were performed either in the USA, Canada, France, Norway or Germany. Age of participants ranged from 0 to 18 years. Study size ranged from 417 to 2 127 452 participants. In seven of the studies, cases were derived from cancer registries, whereas in the remaining four studies they came from other sources.
Ten studies provided data for calculation of OR (95% CI) of risk of neuroblastoma in subjects with high birth weight (44000 g), compared with those below this cutoff value. In Figure 2 , the forest plot with ORs and 95% CIs and the pooled estimate for risk of neuroblastoma in subjects with high birth weight are shown. High birth weight was associated with increased risk of neuroblastoma. This effect measure was identical when using the random-effects model as well as the fixed-effects model (OR 1.19; 95% CI 1.04-1.36). According to I 2 , 0% of the total variation across studies was due to heterogeneity. Influence analysis (random-effects model) showed that the pooled estimate was very robust: omission of individual study estimates led to pooled ORs ranging from 1.17 (95% CI 1.01-1.36) to 1.20 (95% CI 1.04-1.40). No indication for publication bias was found, as investigated by visual inspection of the funnel plots (not shown), and Begg's test (P ¼ 0.28) and Egger's test (P ¼ 0.50).
Ten studies gave data for calculation of OR (95% CI) of risk of neuroblastoma in subjects with low birth weight (<2500 g), compared with those above this cutoff value. Figure 3 shows the forest plot with ORs and 95% CIs and the pooled estimate for risk of neuroblastoma after low birth weight. Low birth weight was related to increased risk of neuroblastoma by random-effects model (OR 1.24; 95% CI 1.0-1.55) as well as by using the fixed-effects model (OR 1.24; 95% CI 1.04-1.50). According to I 2 , 30% of the total variation across studies was due to heterogeneity. Omission of individual studies revealed that no particular study had a major influence on the pooled estimate, with pooled ORs ranging from 1.16 (95% CI 0.97-1.39) to 1.30 (95% CI 1.04-1.61).
Given these findings of increased risk of neuroblastoma at both ends of the birth weight spectrum, we repeated the dichotomous comparisons, now using 'normal birth weight' (2500-4000 g) as reference for all studies that gave data on both low and high birth weight (n ¼ 10 studies). Pooled estimates after high Table 1 Characteristics of studies on the relation between birth weight and risk of neuroblastoma To quantitatively describe this U-shaped relation between birth weight and risk of neuroblastoma, we first checked whether the individual studies fulfilled the assumption of a quadratic model. Since all studies except one 29 did so, we pooled the linear and quadratic regression coefficients from the remaining 11 single studies obtained by the pool-first method. Both the linear regression coefficient (0.52; 95% CI 0.28-0.96) as well as the quadratic regression coefficient (1.10; 95% CI 1.01-1.20) were different from 1.0.
To further investigate the association with both high and low birth weight, we performed sensitivity analysis. Regarding the association with high birth weight, region-specific pooled estimates showed no large differences ( Table 2 ). The association with low birth weight was more pronounced in studies from Europe than in those performed in the USA or Canada. The method of obtaining data on birth weight did not influence the strength of the association with high birth weight. By contrast, it had a strong effect on the association with low birth weight: studies that used interview-based data showed 460% increased risk, whereas those that relied on data from registries had a much smaller estimate. Although the method of obtaining the case diagnosis had no large effect on the estimate for high birth weight, or on the one for low birth weight, the estimate for low birth weight was strongly influenced by source of controls, with registry-based studies showing smaller effects (Table 2) .
Since the sensitivity analysis thereby indicated a considerable bias for low birth weight, we repeated the 'pool-first' analysis, now using only birth weight data 42500 g, which came from studies that used registries to obtain birth weight. These data from the individual studies indicated a linear positive relation between birth weight and risk of neuroblastoma 42500 g. Using these data, we therefore calculated linear regression coefficients for the individual studies. Pooling of these linear regression coefficients revealed that above 2500 g, each 1000-g increase in birth weight was associated with a 13% (95% CI 3-25) increase in risk of neuroblastoma.
Discussion
A number of studies and meta-analyses have shown that birth weight is associated with risk of different Figure 2 Odds ratios for neuroblastoma in subjects with high birth weight (44000 g), as compared with a birth weight of <4000 g (random-effects model) BIRTH WEIGHT AND NEUROBLASTOMA types of tumours in infants and children, like leukaemia, 30 Wilms' tumour 31 and brain tumours. 32 Regarding neuroblastoma, however, the evidence appeared to remain inconclusive. This meta-analysis, on first view, indicates that birth weight might be related to neuroblastoma risk in a U-shaped manner. High as well as low birth weights are followed by an increased risk of developing neuroblastoma in later life. However, our sensitivity analysis gave clear indication for bias in the case of low Figure 3 Odds ratios for neuroblastoma in subjects with low birth weight (<2500 g), as compared with a birth weight of 42500 g (random-effects model) birth weight, with studies using interview data reporting stronger associations than those that used registries as data sources. Remarkably, the results of this meta-analysis are in some contrast to the conclusions drawn by authors of the individual studies. In only one of the publications 13 it was explicitly concluded that high birth weight is a risk factor for neuroblastoma, whereas a further three groups concluded that low birth weight is associated with neuroblastoma. 21, 23, 24 In only two studies, 26, 28 the authors concluded that a U-shaped relation exists, as described here. In four reports it is stated that no association exists with birth weight, 22, 25, 27, 29 whereas the authors of one study did not comment on this issue. 11 At least in some cases, the authors of individual studies might have overlooked an association with high birth weight, either since it was not statistically significant, or since the choice of the reference stratum for birth weight might have 'masked' the result (see also Table 1 , last column for the original study results, as they were calculated by the authors of the studies).
In addition to the problem of measurement error of birth weight, which cannot be fully disregarded, studies on associations between birth weight and later outcome are prone to confounding in multiple ways. Adjustment for confounders has been performed in the studies included here mainly by matching. However, matching was generally restricted to only two variables: age and gender. In four of the studies, [21] [22] [23] 28 additional adjustments were made, mainly for socio-economic status and ethnicity. Adjusted estimates, however, did not differ largely from the unadjusted results. In only one study, 28 birth weight has been adjusted for gestational age, which, again, did not change the result. Although lack of adjustment leaves the possibility that the associations observed might also be related to the degree of maturity of the child at birth, such a relation between gestational age and neuroblastoma risk was only present in two of the studies, 22, 29 but not in the remaining six 11, 13, 23, [26] [27] [28] that investigated this variable.
Although the relation between high birth weight and risk of neuroblastoma was only weak, we observed an unusually high degree of homogeneity between the single study results. According to I 2 , a meanwhile established indicator of betweenstudy-heterogeneity, 19 0% of the variation across studies was due to heterogeneity. On the one hand, this might indicate a highly constant association between high birth weight and neuroblastoma risk: it might, on the other hand, also raise questions regarding other potential reasons for this extreme betweenstudy homogeneity. Recently, Ioannidis et al. have suggested a number of such potential alternative reasons for this phenomenon. 33 Among them, only the issue of correlated data resulting from studies that came from identical authors or overlapping patient groups is relevant in the context of this meta-analysis. We therefore checked whether there was any overlap in study region or year of diagnosis between the studies and included the relevant information in Table 1 . However, we did not find indication that a considerable overlap between any of the study populations could explain our findings. Moreover, influence analysis showed that the effect measure of the relation between high birth weight and risk of neuroblastoma was very robust. The association with high birth weight was also present in the largest study, which is also the only cohort study on this issue, 29 supporting the validity of the estimate. Furthermore, in two out of three studies that reported estimates for birth weight 44500 g 23, 28 ,29 risk of neuroblastoma was further increased in this category of 'very high' birth weight.
Sensitivity analysis indicated that the first notion that low birth weight is also associated with increased risk of neuroblastoma might be biased by maternal recall because interview-based studies gave stronger estimates than studies in which birth-weight data came from more objective sources like birth registries and birth records. One might speculate that mothers of children with neuroblastoma and a relatively low birth weight might recall their babies' birth weight even lower than it was. Alternatively, selection bias might have occurred. Interview participation is known to be skewed towards higher socio-economic status, which itself is related to low birth weight. 34 This interpretation is further supported by the result of stratification by source of controls. For low birth weight, studies which used methods that required active participation (like telephone interviews) gave higher estimates than those which used less biased sources (like registries) to recruit controls. However, in the three case-control studies that reported response proportions of cases and controls they did not differ greatly in this parameter (cases: 73%, controls: 72%; 23 cases: 69%, controls: 71%; 26 cases: 80%, controls: 62-69% 21 ). Moreover, there are other possible explanations for the observed differences. One might be an under-representation of low-birth-weight children in the control group as discussed by Schuz and Forman, 35 which could have caused the results at least in the German study. 21 Since low education and income are associated with increased risk of low birth weight, as mentioned above, to the extent that the controls have fewer low birth weight infants, an increased OR would result from response bias.
During recent years, it has been suggested that neuroblastoma in infancy and in later childhood represent different entities. 36 We therefore additionally checked whether the strength of the association between high birth weight and risk of neuroblastoma differs by age of manifestation. In four of the studies, 13, 26, 28, 29 results were stratified by age. Interestingly, in three of them the association with high birth weight was stronger in infants below 1 year of age, as compared with older children. Further studies are needed to investigate whether a specific subtype of neuroblastoma that manifest in infancy is particularly vulnerable to prenatal influences. Moreover, one has to mention that in none of the studies stage of disease was related to birth weight, leaving the question open whether there is a relation between prenatally acting risk factors and particularly aggressive forms of neuroblastoma.
Since it cannot be assumed that birth weight or fetal growth per se is a causal factor leading to later disease risks, as recently again emphasized by Basso, 37 the key question concerns the mechanisms underlying associations between high birth weight and risk of neuroblastoma. Among the factors that stimulate prenatal weight gain maternal diabetes mellitus might be the most prevalent. It is well established that maternal diabetes leads to excess weight gain in utero and, consequently, to increased birth weight, 38 as even shown in a randomized trial. 39 Remarkably, one of the studies included in this meta-analysis showed that maternal diabetes, in particular gestational diabetes, is associated with an increased risk of neuroblastoma in the offspring, 22 whereas, however, another study did not observe an association. 23 On the population level, maternal diabetes during pregnancy, particularly gestational diabetes that was estimated to affect up to 14% of pregnant women, 40 is likely to be the most important risk factor for high birth weight, leading to a 2-3-fold increased risk. 41 Similar applies to maternal overweight during pregnancy. However, it is obvious that one might only speculate whether this proportion is large enough to explain the 19% increase in risk of neuroblastoma after high birth weight.
During recent years some studies have found an increase in the incidence of neuroblastoma in the general population: in Europe, the age-standardized incidence rate for infants increased from 35.4 to 57.8 per 1 000 000. 42 It has been discussed that these increases cannot be completely attributed to intensified screening. 42, 43 If the association between high birth weight and neuroblastoma risk exists, it might offer a provocative explanation for this trend over time since birth weight, as well as the incidence of high birth weight, has been increasing continuously in the USA and Europe in recent years, ranging from a 6.9% increase (Switzerland) to a 25% increase (Sweden) over the last 20 years in European countries. 44, 45 However, as in the case of maternal diabetes discussed above, it remains speculative whether this trend is strong enough to explain the trend over time in the incidence of neuroblastoma.
Taken together, this meta-analysis shows that high birth weight is a risk factor for neuroblastoma. Previous observations that low birth weight is related to increased risk of neuroblastoma 14 might be distorted by bias. However, on the basis of the currently published literature it cannot be excluded that low birth weight is also a risk factor for neuroblastoma, and as data exist showing that rapid early weight gain, which is frequent in low-birth-weight babies, is also associated with increased risk of neuroblastoma. 46 Further studies on perinatal risk factors for neuroblastoma should focus on maternal diseases and conditions that lead to excessive weight gain during critical periods of early development. If additional studies support the suggestion that gestational diabetes could be an underlying causal factor in this regard, screening for and therapy of gestational diabetes would be a respective preventive measure.
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